Value creation potential of intellectual capital in biotechnology - Empirical evidence from Finland

Raine Hermans*, Ilkka Kauranen

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

54 Citations (Scopus)

Abstract

The objective of the study was to empirically verify impacts of intellectual capital (IC) to the anticipated future sales of small- and medium-sized companies within the biotechnology industry. The study creates and develops tools for the valuation of companies by relating the existing intangibles and the expected value creation of the companies in that industry displaying high growth prospects but long and insecure product development phases. Theoretically, IC is divided into the following three categories: human capital (HC), structural capital (SC), and relational capital (RC). In the empirical setting, survey data of small- and medium-sized Finnish biotechnology companies are used. In the econometric analyses, the interactions, or empirical co-variation, between the three categories of IC explain two-thirds of the variance in the anticipated future sales of the sample companies. Thus, it seems that a well-balanced combination of HC, SC, and RC implies value creation potential and high anticipated future sales.

Original languageEnglish
Pages (from-to)171-185
Number of pages15
JournalR and D Management
Volume35
Issue number2
DOIs
Publication statusPublished - Mar 2005
MoE publication typeA1 Journal article-refereed

Fingerprint Dive into the research topics of 'Value creation potential of intellectual capital in biotechnology - Empirical evidence from Finland'. Together they form a unique fingerprint.

Cite this